EU urologists say case is clear for more prostate screening
This article was originally published in Clinica
Executive Summary
Three-quarters of the 346,000 or so new cases of prostate cancer in Europe every year are diagnosed in the early stages of disease, resulting in an 80% survival rate, thanks to screening initiatives. So said the European Association of Urology (EUA) last week, in calls to improve prostate screening (for benign prostatic hyperplasia and cancer) and care for the other leading urological conditions: incontinence and erectile dysfunction.